Zurück
Sven Stegemann
Contact
T
+49 241 80-23195
Raum
Leibniz first in Translation 1.OG
E-Mail Adresse anzeigen
Geschäftsführende Leitung fiT

Prof. Dr. Sven Stegemann

Contact
T
+49 241 80-23195
Raum
Leibniz first in Translation 1.OG
E-Mail Adresse anzeigen
Forschungsinteresse

Sven Stegemann ist CEO des fiT - Leibniz Joint Lab First in Translation

Titel/Autoren DOI-LINK Magazine Jahre
Patient Engagement in Pharmaceutical Development: Where Are We? – Report from a Symposium
S. Stegemann, A. Birna Almarsdόttir and C. Vermehren
 https://doi.org/10.1016/j.ejpb.2023.02.005 European Journal of Pharmaceutics and Biopharmaceutics 2023
Patient Engagement in Pharmaceutical Development: Where are we? – Report from a symposium
S. Stegemann, A. B. Almarsdόttir, C. Vermehren
 https://doi.org/10.1016/j.ejpb.2023.02.005 European Journal of Pharmaceutics and Biopharmaceutics 2023
  • Publikation

    Patient Engagement in Pharmaceutical Development: Where Are We? – Report from a Symposium

    S. Stegemann, A. Birna Almarsdόttir and C. Vermehren
    European Journal of Pharmaceutics and Biopharmaceutics Vol. 185 (2023)
    https://doi.org/10.1016/j.ejpb.2023.02.005
  • Publikation

    Patient Engagement in Pharmaceutical Development: Where are we? – Report from a symposium

    S. Stegemann, A. B. Almarsdόttir, C. Vermehren
    European Journal of Pharmaceutics and Biopharmaceutics Vol. 185 1-4 (2023)
    https://doi.org/10.1016/j.ejpb.2023.02.005